Agcetech PharmaceuticalsLiabili Ty Partnership Profile
Key Indicators
- Obligation of Contribution ₹ 0.28 M
- Company Age 14 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
About Agcetech PharmaceuticalsLiabili Ty Partnership
Agcetech Pharmaceuticals Limited Liabili Ty Partnership (APLLTP) is 14 Year, 20 Days old Limited Liability Partnership 12 January 2011. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.28 M as per MCA.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAA-3374
-
Incorporation Date
12 Jan 2011
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Mumbai
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Agcetech PharmaceuticalsLiabili Ty Partnership?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Ganjwala
|
Designated Partner | 12-Jan-2011 | Current |
|
Rupa Ganjwala
|
Designated Partner | 12-Jan-2011 | Current |
Financial Performance of Agcetech PharmaceuticalsLiabili Ty Partnership.
Enhance accessibility to Agcetech PharmaceuticalsLiabili Ty Partnership's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agcetech PharmaceuticalsLiabili Ty Partnership?
Unlock access to Agcetech PharmaceuticalsLiabili Ty Partnership's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Innergize Solutions Private LimitedNilesh Ganjwala and Rupa Ganjwala are mutual person
-
Sicomoro Advisors Private LimitedNilesh Ganjwala is a mutual person
-
Maldan Engineering Pvt LtdNilesh Ganjwala and Rupa Ganjwala are mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Agcetech PharmaceuticalsLiabili Ty Partnership?
Unlock and access historical data on people associated with Agcetech PharmaceuticalsLiabili Ty Partnership, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agcetech PharmaceuticalsLiabili Ty Partnership, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agcetech PharmaceuticalsLiabili Ty Partnership's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.